[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=84112]], camposKey:1876-0341 2024-06-01 COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study939946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=86559]], camposKey:2169-3536 2024-01-01 Breast carcinoma prediction through integration of machine learning models00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80375]], camposKey:2072-6694 2023-09-01 Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77449]], camposKey:1130-0108 2023-04-01 Median arcuate ligament syndrome: a rare cause of abdominal pain219220, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77450]], camposKey:2617-2216 2023-03-30 Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77451]], camposKey:0014-2565 2023-03-01 Effect of semaglutide on fatty liver disease biomarkers in patients with diabetes and obesity Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad134143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77452]], camposKey:1130-0108 2023-02-01 DRESS syndrome secondary to carbamazepine9697, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76166]], camposKey:0026-4806 2023-02-01 High cobalamin levels as a five-year risk predictor for developing hematological cancer2228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77547]], camposKey:0014-2565 2023-01-01 Efecto de semaglutida sobre los biomarcadores de la enfermedad del hígado graso en pacientes con diabetes y obesidad134143, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77453]], camposKey:0300-7995 2023-01-01 Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77551]], camposKey:0211-139X 2023-01-01 RÉPLICA A «Consideraciones al manuscrito cáncer y población geriátrica: ¿dos conceptos incompatibles para la realización de cuidados intensivos?»520, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77454]], camposKey:0211-139X 2023-01-01 Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?» RÉPLICA A «Consideraciones al manuscrito cáncer y población geriátrica: ¿dos conceptos incompatibles para la realización de cuidados intensivos?»00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81222]], camposKey:2523-1995 2023-01-01 The relationship between PARP inhibitors with the relapse and leukemisation of lymphomas: a case report , com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77455]], camposKey:1471-2318 2022-12-01 Differences in clinical features and mortality in very old unvaccinated patients (¿ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77337]], camposKey:1664-2392 2022-09-16 Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77456]], camposKey:0211-139X 2022-09-01 Cancer and elderly: Two incompatible concepts for intensive care? Cáncer y población geriátrica: ¿dos conceptos incompatibles para la realización de cuidados intensivos?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77457]], camposKey:0025-7753 2022-07-08 Association of blood group A with hospital comorbidity in patients infected by SARS-CoV-2 Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-22730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77458]], camposKey:1664-2392 2022-06-24 Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75591]], camposKey:2077-0383 2022-06-01 Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77459]], camposKey:0002-8614 2022-05-01 Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure15851589, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77460]], camposKey:2768-6701 2022-03-01 Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77462]], camposKey:0742-3071 2022-02-01 Basal insulin analogues in people with diabetes and chronic kidney disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77461]], camposKey:2227-9059 2022-02-01 Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77541]], camposKey:0025-7753 2022-01-01 Asociación del grupo sanguíneo A con mayor comorbilidad hospitalaria en pacientes infectados por SARS-CoV-22730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77536]], camposKey:0211-139X 2022-01-01 Cáncer y población geriátrica:: ¿dos conceptos incompatibles para la realización de cuidados intensivos?2860, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77463]], camposKey:2075-1729 2021-12-01 Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65946]], camposKey:1076-1608 2021-12-01 Sclerodermiform Syndrome Induced by Hydroxycarbamide00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77464]], camposKey:0014-2565 2021-10-01 Porcelain aorta Aorta en porcelana00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77465]], camposKey:2076-3417 2021-09-01 The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74163]], camposKey:2075-4426 2021-07-01 Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77338]], camposKey:0014-2565 2021-05-01 Is Nutrition the Forgotten Risk Factor in COVID19 Infection?311312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77467]], camposKey:0014-2565 2021-05-01 Is Nutrition the Forgotten Risk Factor in COVID-19 Infection? ¿Es la nutrición el factor de riesgo olvidado en la infección por COVID-19?311312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77466]], camposKey:2077-0383 2021-05-01 Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77339]], camposKey:2574-0954 2021-03-01 Black esophagus and diabetes: a close relationship5961, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72051]], camposKey:2218-273X 2021-02-01 Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77540]], camposKey:0014-2565 2021-01-01 Aorta en porcelana4930, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77340]], camposKey:0021-9150 2021-01-01 Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study5258, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64713]], camposKey:0014-2565 2021-01-01 ¿Es la nutrición el factor de riesgo olvidado en la infección por COVID-19?311312, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76541]], camposKey:2077-0383 2021-01-01 Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61382]], camposKey:0300-7995 2021-01-01 The nutritional status of the elderly patient infected with COVID-19: the forgotten risk factor?549554, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77341]], camposKey:0014-2565 2020-11-01 Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination511517, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77343]], camposKey:0014-2565 2020-10-01 Heart failure and diabetes, opportunities for improving treatment through patient characterisation437438, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65748]], camposKey:0300-8932 2020-10-01 Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART828834, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66396]], camposKey:0953-6205 2020-10-01 VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension6065, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77342]], camposKey:0923-7534 2020-09-01 Impact of systemic treatment versus best supportive care on survival in patients older than 80 years with cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77344]], camposKey:1462-8902 2020-09-01 In response to the paper 'High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors?'17011702, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77346]], camposKey:2045-2322 2020-02-14 A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function (vol 9, 5055, 2019)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77345]], camposKey:0732-183X 2020-02-10 Use of glycosylated hemoglobin and C-peptide levels in the diagnosis and prevention of type 1 diabetes mellitus as an immune-related adverse event secondary to treatment with immunotherapy in solid tumors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63235]], camposKey:1828-0447 2020-01-01 Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events15331544, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77545]], camposKey:0300-8932 2020-01-01 Incidencia de eventos cardiovasculares y cambios en el riesgo estimado y en el tratamiento de la hipercolesterolemia familiar: registro SAFEHEART828834, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77534]], camposKey:0014-2565 2020-01-01 Insuficiencia cardíaca y diabetes, oportunidades de mejora en el tratamiento a través de la caracterización de pacientes437438, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77347]], camposKey:0085-2538 2020-01-01 Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?213213, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77544]], camposKey:0014-2565 2020-01-01 La inflamación, la desnutrición y la infección por SARS-CoV-2: una combinación nefasta511517, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77349]], camposKey:1933-2874 2019-12-01 Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study989996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77348]], camposKey:0168-8227 2019-12-01 Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77353]], camposKey:0021-9541 2019-07-01 In response to Yaribeygi et al. "Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"99069907, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77350]], camposKey:0014-2565 2019-05-01 Diuretic treatment of the patient with diabetes and heart failure. Role of SGLT2 inhibitors and similarities with carbonic anhydrase inhibitors208217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77352]], camposKey:2213-8587 2019-05-01 GLP-1 and the renin-angiotensin-aldosterone system337337, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77351]], camposKey:2045-2322 2019-03-25 A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77354]], camposKey:0168-8227 2019-02-01 Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis1013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77550]], camposKey:0014-2565 2019-01-01 Tratamiento diurético del paciente con diabetes e insuficiencia cardiaca. El papel de los inhibidores de la SGLT2 y semejanzas con los inhibidores de la anhidrasa carbónica208217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53649]], camposKey:0021-9150 2019-01-01 VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia1722, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77355]], camposKey:1931-857X 2018-11-01 Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77356]], camposKey:1933-2874 2018-08-01 Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART study948957, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77468]], camposKey:0953-6205 2018-06-01 Use of degludec insulin in chronic complex patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77358]], camposKey:1081-5589 2018-02-01 Reply to "Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes' by Yoshimoto et al.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77357]], camposKey:1388-9842 2018-02-01 The mechanism of action of sodium-glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors409409, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77359]], camposKey:0025-7753 2018-01-12 Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?3338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77555]], camposKey:0025-7753 2018-01-01 Actualización del concepto del bloqueo dual del sistema renina-angiotensina-aldosterona. ¿Una nueva opción terapéutica?3338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77553]], camposKey:2530-0792 2018-01-01 Diabetes tipo 2 bien contralada y microalbuinuria2426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77361]], camposKey:0021-9150 2017-08-01 CARDIOVASCULAR RISK IN HIV-INFECTED WOMEN00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77360]], camposKey:0021-9150 2017-08-01 FAMILIAL HYPERCHOLESTEROLEMIA AND THE DIABETOGENIC EFFECT OF STATINS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77362]], camposKey:2092-6715 2017-07-01 I Can Not Wear My Sunglasses: An Unusual Sarcoidosis Presentation226228, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77363]], camposKey:0009-7322 2017-05-30 Predicting Cardiovascular Events in Familial Hypercholesterolemia The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)21330, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77365]], camposKey:1079-5642 2016-09-01 Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study)20042010, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77366]], camposKey:1933-2874 2016-08-01 Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry953961, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77364]], camposKey:0195-668X 2016-08-01 Do we reach the LDL-c goals in Familial hypercholesterolemiapatients under Eighteen Years Old? SAFEHEART (Spanish Familial Hypercholesterolemia Longitudinal Cohort Study) follow-up study10131013, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77367]], camposKey:0735-1097 2016-03-22 Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia 5-Year SAFEHEART Registry Follow-Up12781285, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77368]], camposKey:1738-6586 2016-01-01 Neurological Involvement in Erdheim-Chester Disease115116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77369]], camposKey:1046-6673 2015-08-01 Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3 '-Untranslated Region Polymorphism C+87T by MicroRNA-10718161825, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77371]], camposKey:0735-1097 2014-04-22 Genetic Implication of a Novel Thiamine Transporter in Human Hypertension15421555, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77372]], camposKey:0022-3042 2014-04-01 Chromogranin B: intra-and extra-cellular mechanisms to regulate catecholamine storage and release, in the catecholaminergic cells and organisms4859, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77370]], camposKey:0892-6638 2014-04-01 Regulation of chromogranin A by hsa-miR-107 in hypertension and nephropathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77373]], camposKey:0022-3042 2013-12-01 Genetic variation at the delta-sarcoglycan (SGCD) locus elevates heritable sympathetic nerve activity in human twin pairs750761, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77374]], camposKey:0964-6906 2013-09-15 MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension36243640, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77375]], camposKey:0014-2565 2013-01-01 Being a physician ... "and initiate a post doctorate stay in the USA"6265, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77376]], camposKey:0263-6352 2013-01-01 Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y-2 receptor promoter disrupt multiple transcriptional response motifs123133, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77554]], camposKey:0014-2565 2013-01-01 Ser médico... "e iniciar una estancia posdoctoral en Estados Unidos"6265, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77377]], camposKey:0735-1097 2012-11-20 Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses (vol 60, pg 1678, 2012)22612261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77378]], camposKey:0735-1097 2012-10-23 Neuropeptide Y (NPY) Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses16781689, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77469]], camposKey:0025-7753 2012-03-03 Four-month history of weakness of lower limbs in a 50-years-old male Debilidad de miembros inferiores de cuatro meses de evolución en un varón de 50 años00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77537]], camposKey:0025-7753 2012-01-01 Debilidad de miembros inferiores de cuatro meses de evolución en un varón de 50 años2300, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77470]], camposKey:0025-7753 2011-11-12 Dyspnea of one-month duration in a 62 years-old woman Disnea de un mes de evolución en una mujer de 62 años00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77546]], camposKey:0214-8986 2011-01-01 Destrucción del carpo secundaria a gota sin tratamiento1480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77543]], camposKey:0025-7753 2011-01-01 Disnea de un mes de evolución en una mujer de 62 años5740, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77548]], camposKey:0214-8986 2010-01-01 Anemia hemolítica inducida por amoxicilina-clavulánico566567, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77538]], camposKey:1137-6627 2010-01-01 Endocarditis secundaria a cateter de derivación ventriculo-atrial9395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77379]], camposKey:1137-6627 2010-01-01 Secondary endocarditis to ventriculo-atrial shunt9395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77471]], camposKey:1137-6627 2010-01-01 Secondary endocarditis to ventriculo-atrial shunt Endocarditis secundaria a catéter de derivación ventrículo-atrial9395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77472]], camposKey:0014-2565 2009-05-01 Pleural effusion and arthralgias in relation to very advanced rheumatoid arthritis Derrame pleural y artralgias en relación con artritis reumatoide muy evolucionada250251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77473]], camposKey:1130-0108 2009-01-01 Abdominal pain for 9 days Dolor abdominal de 9 días de evolución424426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77552]], camposKey:0014-2565 2009-01-01 Derrame pleural y artralgias en relación con artritis reumatoide muy evolucionada250251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77535]], camposKey:0025-7753 2009-01-01 Síndrome de watermelon6480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77336]], camposKey:0014-2565 2008-06-01 Wallemberg's syndrome in patient without vascular risk factors319320, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77539]], camposKey:0304-5412 2008-01-01 Hipoglucemia en pacientes diabéticos tipo 212041207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77474]], camposKey:0304-5412 2008-01-01 Hypoglycemia in type 2 diabetic patients Hipoglucemia en pacientes diabéticos tipo 212041207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77549]], camposKey:0304-5412 2008-01-01 Protocolo diagnóstico de la hiperglucemia en el embarazo y tratamiento de la diabetes gestacional11521157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77542]], camposKey:0304-5412 2008-01-01 Protocolo terapéutico de la hipoglucemia12171218, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77475]], camposKey:0304-5412 2008-01-01 Therapeutic protocol for hypoglycemia Protocolo terapéutico de la hipoglucemia12171218][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=30909]},camposKey: 138 0 Utilidad de los Hilos en Twitter para mejorar las habilidades para lalectura del electrocardiograma en estudiantes de medicina: TwittUVA-ECG, estudio cuasi-experimental comparando antes-después de la intervención 978-84-18321-43-6Actas del Congreso Internacional Virtual USATIC 2022, Ubicuo y Social: Aprendizaje con TIC 1 2022-01-01 Servicio de Publicaciones ][][][][][][][][][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7a00f3bd][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3241], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c1c54]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1789b, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1784c, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16f19, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16cbc][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=33720]},camposKey: El internista ante el desafío diagnóstico de la enfermedad de Castleman 978-84-18866-75-3Casos Clínicos del 42º Congreso Nacional de la Sociedad Española de Medicina Interna (SEMI) 1 2021-01-01 CTO Editorial, SL]